Natalizumab Treatment of Relapsing Remitting Multiple Sclerosis Has No Long-Term Effects on the Proportion of Circulating Regulatory T Cells

被引：0
|
作者：
Radu Tanasescu
Nanci Frakich
I.-Jun Chou
Perla Filippini
Giulio Podda
Gao Xin
Ranjithmenon Muraleedharan
Oltita Jerca
David Onion
Cris S. Constantinescu
机构：
[1] University of Nottingham,Academic Unit of Mental Health and Clinical Neuroscience
[2] Nottingham University Hospitals NHS Trust,Department of Neurology
[3] Nottingham University Hospital NHS Trust,Nottingham Centre for MS and Neuroinflammation
[4] Chang Gung Memorial Hospital,Department of Neurology
[5] Broad Institute of Massachusetts Institute of Technology and Harvard University,School of Life Sciences
[6] University of Nottingham,Department of Neurology, Cooper Neurological Institute
[7] Cooper Medical School of Rowan University,undefined
[8] Wye Valley NHS Trust,undefined
[9] Medizinisches Zentrum Harz,undefined
来源：
Neurology and Therapy | 2023年 / 12卷
关键词：
CCR5; Foxp3; Multiple sclerosis; Natalizumab; Regulatory T cells;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2041 / 2052
页数：11
相关论文
共 50 条
  • [1] Natalizumab Treatment of Relapsing Remitting Multiple Sclerosis Has No Long-Term Effects on the Proportion of Circulating Regulatory T Cells
    Tanasescu, Radu
    Frakich, Nanci
    Chou, I. -Jun
    Filippini, Perla
    Podda, Giulio
    Xin, Gao
    Muraleedharan, Ranjithmenon
    Jerca, Oltita
    Onion, David
    Constantinescu, Cris S.
    NEUROLOGY AND THERAPY, 2023, 12 (06) : 2041 - 2052
  • [2] Long-term effect of natalizumab in relapsing-remitting multiple sclerosis: TYSTEN cohort
    Bigaut, K.
    Fabacher, T.
    Kremer, L.
    Ongagna, J. -C.
    Kwiat-Kowski, A.
    Sellal, F.
    Ferriby, D.
    Courtois, S.
    Vermersch, P.
    Collongues, N.
    Zephir, H.
    De Seze, J.
    Outteryck, O.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 536 - 536
  • [3] Long-term effects of natalizumab on MRI activity and clinical outcomes in Japanese patients with relapsing-remitting multiple sclerosis
    Takahiko Saida
    Qi Hao
    Michihiro Kanda
    Yumiko Tani
    BMC Neurology, 23
  • [4] Long-term effects of natalizumab on MRI activity and clinical outcomes in Japanese patients with relapsing-remitting multiple sclerosis
    Saida, Takahiko
    Hao, Qi
    Kanda, Michihiro
    Tani, Yumiko
    BMC NEUROLOGY, 2023, 23 (01)
  • [5] Long-term safety and efficacy of natalizumab in relapsing-remitting multiple sclerosis: impact on quality of life
    Planas, Raquel
    Martin, Roland
    Sospedra, Mireia
    PATIENT-RELATED OUTCOME MEASURES, 2014, 5 : 25 - 33
  • [6] Long-term disease activity and disability progression in relapsing-remitting multiple sclerosis patients on natalizumab
    Dekker, I
    Leurs, C. E.
    Hagens, M. H. J.
    van Kempen, Z. L. E.
    Kleerekooper, I
    Lissenberg-Witte, B., I
    Barkhof, F.
    Uitdehaag, B. M. J.
    Balk, L. J.
    Wattjes, M. P.
    Killestein, J.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 33 : 82 - 87
  • [7] Residual adaptive inflammation in the cerebrospinal fluid after long-term natalizumab treatment in patients with relapsing-remitting multiple sclerosis
    Buhelt, Sophie
    Hansen, Malene Bredahl
    Soendergaard, Helle Bach
    El Mahdaoui, Sahla
    Hansen, Marie Mathilde
    Mahler, Mie Reith
    Christensen, Jeppe Romme
    Sellebjerg, Finn
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 580 - 580
  • [8] Long-term effect of natalizumab in a French cohort of patients with relapsing-remitting multiple sclerosis: TYSTEN cohort
    Bigaut, Kevin
    Fabacher, Thibaut
    Collongues, Nicolas
    Kremer, Laurent
    Fleury, Marie-Celine
    Ongagna, Jean-Claude
    De Seze, Jerome
    NEUROLOGY, 2018, 90
  • [9] Case History Long-Term Treatment of relapsing-remitting MS with Natalizumab
    Sievers, Carsten
    NERVENHEILKUNDE, 2013, 32 (10) : 786 - 786
  • [10] THE LONG-TERM VALUE OF GLATIRAMER ACETATE FOR THE TREATMENT OF RELAPSING REMITTING MULTIPLE SCLEROSIS IN THE NETHERLANDS
    Wilson, L. E.
    Prufert, A.
    VALUE IN HEALTH, 2014, 17 (07) : A398 - A399
12345